- The pharmacokinetic parameters for VACV, ACV and CMMG - Relationship between ALDH2 genotypes and the pharmacokinetics of VACV, ACV and CMMG in blood [clinicaltrials_resource:2b618bfd7fc2e46f1d43f13a14d05fb2]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
- The pharmacokinetic parameters for VACV, ACV and CMMG - Relationship between ALDH2 genotypes and the pharmacokinetics of VACV, ACV and CMMG in blood [clinicaltrials_resource:2b618bfd7fc2e46f1d43f13a14d05fb2]
Bio2RDF identifier
2b618bfd7fc2e46f1d43f13a14d05fb2
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:2b618bfd7fc2e46f1d43f13a14d05fb2
measure [clinicaltrials_vocabulary:measure]
- The pharmacokinetic paramete ...... of VACV, ACV and CMMG in blood
identifier
clinicaltrials_resource:2b618bfd7fc2e46f1d43f13a14d05fb2
title
- The pharmacokinetic paramete ...... of VACV, ACV and CMMG in blood
@en
type
label
- The pharmacokinetic paramete ...... 18bfd7fc2e46f1d43f13a14d05fb2]
@en